Please select first letter of the drug, then select name
from the list in the second window and click Go!
First letter: list of names:


Aciclovir (INN) (IPA: ) or acyclovir (USAN), marketed as Zovirax, is one of the main antiviral drugs. Gertrude B. Elion was awarded a Nobel Prize in 1988 partly for the discovery of aciclovir. It has been seen as the start of a new era in antiviral therapy, as it is extremely selective and low in cytotoxicity. However, it has a very narrow spectrum, only effective against certain viruses such as HSV-1, HSV-2, and VZV, with limited effectiveness against active EBV, and minimal activity against human cytomegalovirus (CMV). It is about 10 times more potent against HSV than VZV. It does not eradicate latent herpes, and does not work very well against genital herpes in women. Aciclovir is rather different from other nucleoside analogues, for it contains only a partial nucleoside structure as the sugar ring is replaced by an open-chain structure.


1 Mode of action
Acyclovir Drug
2 Pharmacokinetics
3 Metabolism
4 Side effects
5 Indications
6 References

Mode of action
Aciclovir is converted into monophosphate form only by viral thymidine kinase, which is far more effective (3000 times) in phosphorylation than cellular thymidine kinase. Subsequently, the monophosphate form is further phosphorylated into the active triphosphate form, aciclo-GTP, by cellular kinases. Aciclo-GTP is a very potent inhibitor of viral DNA polymerase; it has approximately 100 times higher affinity to viral than cellular polymerase. Its monophosphate form also incorporates into the viral DNA, resulting in chain termination. It has also been shown that the viral enzymes cannot remove acyclo-GMP from the chain, which results in inhibition of further activity of DNA polymerase. Acyclo-GTP is fairly rapidly metabolised within the cell, possibly by cellular phosphatases.

Aciclovir suffers from low water solubility, and also from poor oral absorption, which is only 20%. Orally administered the peak plasma concentration will be reached in 1-2 hours. If large doses are required, aciclovir must be administered intravenously. Aciclovir has a high distribution rate, only 30 % is protein-bound in plasma. The half-life of aciclovir is approximately 3 hours. Aciclovir can also be given topically for treatment of herpes infections of mucous membrane and skin, such as genital herpes or recurrent herpes labialis (cold sore). Prophylactic administration is possible, and is often used for patients who are under immunosuppressant drugs or radiotherapy or for those who are suffering from recurrent genital infection herpes simplex.

The excretion of aciclovir takes place via the renal system, partly by glomerular filtration and partly by tubular secretion. Renal problems have been reported when given in large, fast doses intravenously, due to the crystallisation of aciclovir in the kidneys.

Side effects
Since aciclovir can be incorporated also into the cellular DNA, it is a chromosome mutagen, therefore, its use should be avoided during pregnancy. However it has not been shown to cause any teratogenic nor carcinogenic effects. The acute toxicity (LD50) of aciclovir when given orally is greater than 1mg/kg, due to the low absorption rate from the gastrointestinal tract. Single cases have been reported, where extremely high (up to 80mg/kg) doses have been accidentally given intravenously without causing any side effects. The most common adverse effects are local irritation at the site of injection, headache when given orally, and a stinging and burning sensation when administered topically. The resistance towards aciclovir evolves rather rapidly, although this has not much hindered its clinical use. Resistant forms are most likely viruses that have a mutation in their thymidine kinase or DNA polymerase.

Herpes encephalitis
Herpes genitalis and prophylaxis
Herpes labialis
Herpes zoster
Herpes keratoconjunctivitis

Harvey Stewart C. in Remington’s Pharmaceutical Sciences 18th edition: (ed. Gennard, Alfonso R.) Mack Publishing Company, 1990. ISBN 0912734043.
Huovinen P., Valtonen V. in Kliininen Farmakologia (ed. Neuvonen et. al.). Kandidaattikustannus Oy, 1994. ISBN 9519851179.
Périgaud C., Gosselin G., Imbach J. -L.: Nucleoside analogues as chemotherapeutic agents: a review. Nucleosides and nucleotides 1992; 11(2-4)
Rang H.P., Dale M.M., Ritter J.M.: Pharmacology, 3rd edition. Pearson Professional Ltd, 1995. 2003 (5th) edition ISBN 0443071454; 2001 (4th) edition ISBN 0443065748; 1990 edition ISBN 0443034079
Other useful drug information: Atorvastatin | Flagyl | Donepezil | Flonase | Zanaflex | Mucinex | Adderall

Page Content: acyclovir buy , acyclovir effects side , acyclovir online , acyclovir medication , acyclovir information , acyclovir order , acyclovir buy online , acyclovir prescription , acyclovir ointment , acyclovir pregnancy .

This site is only for information purposes, specific treating and dosage also any information here should not be used
to diagnose or treat health problems.
Regulatory or medical requirements may wary in different countries, this information is intended for U.S. citizens. Copyright © 2006-2012. All Rights Reserved.